Successful adalimumab treatment and usefulness of capsule endoscopy for gut inflammation concomitant with ankylosing spondylitis

References

• Prajzlerová K, Grobelná K, Pavelka K, Šenolt L, Filková M. An update on biomarkers in axial spondyloarthritis. Autoimmun Rev. 2016;15:501–9.
   PubMed Web of Science ®Google Scholar
• De Keyser F, Van den Bosch F, Mielants H. Anti-TNF-alpha therapy in ankylosing spondylitis. Cytokine. 2006;33:294–8.
   PubMed Web of Science ®Google Scholar
• Maxwell LJ, Zochling J, Boonen A, Singh JA, Veras MM, Tanjong Ghogomu E, et al. TNF-alpha inhibitors for ankylosing spondylitis. Cochrane Database Syst Rev. 2015;18:CD005468.
   Google Scholar
• Costello ME, Ciccia F, Willner D, Warrington N, Robinson PC, Gardiner B, et al. Intestinal dysbiosis in ankylosing spondylitis. Arthritis Rheumatol. 2015;67:686–91.
   PubMed Web of Science ®Google Scholar
• Eliakim R, Karban A, Markovits D, Bardan E, Bar-Meir S, Abramowich D, and Scapa E. Comparison of capsule endoscopy with ileocolonoscopy for detecting small-bowel lesions in patients with seronegative spondyloarthropathies. Endoscopy. 2005;37:1165–9.
   PubMed Web of Science ®Google Scholar
• Rimbas M, Nicolau A, Caraiola S, Badea CG, Voiosu MR, and Baicus CR. Small bowel inflammatory involvement in Behçet’s disease associated spondyloarthritis is different from other spondyloarthritides. A prospective cohort study. J Gastrointestin Liver Dis. 2013;22:405–11.
   PubMed Web of Science ®Google Scholar
• Mielants H, Veys EM, Cuvelier C, De Vos M, Goemaere S, De Clercq L, et al. The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint. J Rheumatol. 1995;22:2279–84.
   PubMed Web of Science ®Google Scholar
• Lin P, Bach M, Asquith M, Lee AY, Akileswaran L, Stauffer P, et al. HLA-B27 and human β2-microglobulin affect the gut microbiota of transgenic rats. PLoS One. 2014;9:e105684.
   PubMed Web of Science ®Google Scholar
• Satake M, Sakuraba H, Hiraga H, Hanabata N, Hiraga N, Hasui K, et al. Capsule endoscopy for differentiating early Crohn's disease from Behçet's disease. J Inflam Bowel Dis Disor 2016;1:2. doi:10.4172/jibdd.1000108.
   Google Scholar
• Tanaka M, Saito H, Fukuda S, Sasaki Y, Munakata A, Kudo H. Simple mucosal biopsy criteria differentiating among Crohn disease, ulcerative colitis, and other forms of colitis: measurement of validity. Scand J Gastroenterol. 2000;35:281–6.
   PubMed Web of Science ®Google Scholar
• van der Heijde D, Kivitz A, Schiff MH, Sieper J, Dijkmans BA, Braun J, et al. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2006;54:2136–46.
   PubMed Web of Science ®Google Scholar
• Thjodleifsson B, Geirsson AJ, Björnsson S, Bjarnason I. A common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland. Arthritis Rheum. 2007;56:2633–9.
   PubMedGoogle Scholar
• Ciccia F, Bombardieri M, Principato A, Giardina A, Tripodo C, Porcasi R, et al. Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis Rheum. 2009;60:955–65.
   PubMed Web of Science ®Google Scholar
• Jethwa H, Bowness P. The interleukin (IL)-23/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment. Clin Exp Immunol. 2016;183:30–6.
   PubMed Web of Science ®Google Scholar
• Mei Y, Pan F, Gao J, Ge R, Duan Z, Zeng Z, et al. Increased serum IL-17 and IL-23 in the patient with ankylosing spondylitis. Clin Rheumatol. 2011;30:269–73.
   PubMed Web of Science ®Google Scholar
• Akiyo O, Mitsuhiro M, Harumoto Y. Clinical characteristics of Japanese patients with axial spondyloarthritis, and short-term efficacy of adalimumab. J Orthop Sci. 2015;20:1070–7.
   PubMed Web of Science ®Google Scholar
• Gratacós J, Collado A, Filella X, Sanmartí R, Cañete J, Llena J, et al. Serum cytokines (IL-6, TNF-alpha, IL-1 beta and IFN-gamma) in ankylosing spondylitis: a close correlation between serum IL-6 and disease activity and severity. Br J Rheumatol. 1994;33:927–31.
   PubMedGoogle Scholar
• Jing L, Zheng D, Qi Z, Dongyi H, Yanyun M, Aiping D, et al. TNF-α promoter polymorphisms predict the response to etanercept more powerfully than that to infliximab/adalimumab in spondyloarthritis. Sci Rep. 2016;31:32202.
   Google Scholar
• Bourne T, Fossati G, Nesbitt A. A PEGylated Fab' fragment against tumor necrosis factor for the treatment of Crohn disease: exploring a new mechanism of action. BioDrugs. 2008;22:331–7.
   PubMed Web of Science ®Google Scholar
• Ueda N, Tsukamoto H, Mitoma H, Ayano M, Tanaka A, Ohta S, et al. The cytotoxic effects of certolizumab pegol and golimumab mediated by transmembrane tumor necrosis factor α. Inflamm Bowel Dis. 2013;19:1224–31.
   PubMed Web of Science ®Google Scholar
• Gulen R, Bengi O, Nese O, Asuman M, Gazi Y, BelkÂs U, et al. Association of macroscopic gut inflammation with disease activity, functional status and quality of life in ankylosing spondylitis. Rheumatol Int. 2009;29:755–8.
   PubMed Web of Science ®Google Scholar
• Cypers H, Varkas G, Beeckman S, Debusschere K, Vog T, Roth J, et al. Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis. Ann Rheum Dis. 2015. [Epub ahead of print]. doi:10.1136/annrheumdis-2015-208025.
   PubMed Web of Science ®Google Scholar
• De Vos M, Mielants H, Cuvelier C, Elewaut A, Veys E. Long-term evolution of gut inflammation in patients with spondyloarthropathy. Gastroenterology. 1996;110:1696–703.
   PubMed Web of Science ®Google Scholar
• Van Praet L, Jans L, Carron P, Jacques P, Glorieus E, Colman R, et al. Degree of bone marrow oedema in sacroiliac joints of patients with axial spondyloarthritis is linked to gut inflammation and male sex: results from the GIANT cohort. Ann Rheum Dis. 2014;73:1186–9.
   PubMed Web of Science ®Google Scholar
• Cheifetz AS, Kornbluth AA, Legnani P, Schmelkin I, Brown A, Lichtiger S, et al. The risk of retention of the capsule endoscope in patients with known or suspected Crohn's disease. Am J Gastroenterol. 2006;101:2218–22.
   PubMed Web of Science ®Google Scholar
• Bourreille A, Ignjatovic A, Aabakken L, Loftus EV Jr, Eliakim R, Pennazio M, et al. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus. Endoscopy. 2009;41:618–37.
   PubMed Web of Science ®Google Scholar
• Rudwaleit M, Baeten D. Ankylosing spondylitis and bowel disease. Best Pract Res Clin Rheumatol. 2006;20:451–71.
   PubMed Web of Science ®Google Scholar
• De Vos M. Review article: joint involvement in inflammatory bowel disease. Aliment Pharmacol Ther. 2004;20(Suppl 4):36–42.
   PubMed Web of Science ®Google Scholar